Wolfgang Friess (Wolfgang Frieß)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 4

Top Topics

Molecular Dynamics Simulations

Monoclonal Antibody

Pulmonary Fibrosis

Top Venues

Pharmaceutical research

Science advances

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Oliver Bluemel, Jakob W Buecheler, Astrid Hauptmann, Georg Hoelzl, Karoline Bechtold-Peters, Wolfgang Friess
Scaling Down Large-Scale Thawing of Monoclonal Antibody Solutions: 3D Temperature Profiles, Changes in Concentration, and Density Gradients. Pharmaceutical research (2021)
Michael Gerckens, Kenji Schorpp, Francesco Pelizza, Melanie Wögrath, Kora Reichau, Huilong Ma, Armando-Marco Dworsky, Arunima Sengupta, Mircea-Gabriel Stoleriu, Katharina Heinzelmann, Juliane Merl-Pham, Martin Irmler, Hani N Alsafadi, Eduard Trenkenschuh, Lenka Sarnova, Marketa Jirouskova, Wolfgang Friess, Stefanie M Hauck, Johannes Beckers, Nikolaus Kneidinger, Juergen Behr, Anne Hilgendorff, Kamyar Hadian, Michael Lindner, Melanie Königshoff, Oliver Eickelberg, Martin Gregor, Oliver Plettenburg, Ali Oender Yildirim, Gerald Burgstaller
Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics. Science advances 7 (52) (2021)
Martin Domnowski, Jan Jaehrling, Wolfgang Friess
Assessment of Antibody Self-Interaction by Bio-Layer-Interferometry as a Tool for Early Stage Formulation Development. Pharmaceutical research 37 (2) (2020)
Christin Pohl, Matja Zalar, Inas El Bialy, Sowmya Indrakumar, Günther Herbert Johannes Peters, Wolfgang Friess, Alexander P Golovanov, Werner W Streicher, Allan Noergaard, Pernille Harris
The Effect of Point Mutations on the Biophysical Properties of an Antimicrobial Peptide: Development of a Screening Protocol for Peptide Stability Screening. Molecular pharmaceutics 17 (9) (2020)